What type of study is this?

This is a Systematic Review study (also classified as: Literature Review).

1,3,4‐Thiadiazole Derivatives as VEGFR‐2 Inhibitors and Its Molecular Insight for Cancer Therapy

View Full Paper

Ask AI

Bookmark

Authors

Review highlights 1,3,4-thiadiazole as a key scaffold for VEGFR-2 inhibitors, suggesting future therapeutic directions.

1,3,4-thiadiazole derivatives improve VEGFR-2 inhibition, aiding cancer treatment.
Analysis of 151 TDA-based inhibitors reveals critical insights into selectivity and toxicity.
Systematic review utilized structure-activity relationship to evaluate binding interactions with VEGFR-2.
Study underscores the need for developing more effective and selective VEGFR-2 inhibitors in cancer therapy.

Gawande et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark